Experienced investor and corporate executive with a focus on growth-stage healthcare and technology companies. Patricia France combines operating leadership and capital-allocation experience, having led strategy, M&A and portfolio scaling across public and private markets. She evaluates board and CEO opportunities, prioritizing durable revenue models, unit economics and governance enhancements to drive value creation.
Experienced investor and corporate executive with a focus on growth-stage healthcare and technology companies. Patricia France combines operating leadership and capital-allocation experience, having led strategy, M&A and portfolio scaling across public and private markets. She evaluates board and CEO opportunities, prioritizing durable revenue models, unit economics and governance enhancements to drive value creation.
Combines operational leadership with disciplined growth-stage investing in healthcare and technology, prioritizing durable revenue models, strong unit economics and governance-driven value creation. Prefers board and CEO-level engagements where active strategic oversight, M&A acumen and portfolio scaling accelerate commercialization and margin expansion. Allocates capital with a bias toward companies demonstrating repeatable unit economics, regulatory defensibility and clear exit pathways; uses staged financing, performance milestones and board governance levers to manage downside and amplify long-term returns.
Combines operational leadership with disciplined growth-stage investing in healthcare and technology, prioritizing durable revenue models, strong unit economics and governance-driven value creation. Prefers board and CEO-level engagements where active strategic oversight, M&A acumen and portfolio scaling accelerate commercialization and margin expansion. Allocates capital with a bias toward companies demonstrating repeatable unit economics, regulatory defensibility and clear exit pathways; uses staged financing, performance milestones and board governance levers to manage downside and amplify long-term returns.
| Trades 2242 | Longs Won 1397/2242 62% | Profit Factor 14.25 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $560,191.96 |
| Average Win $112,609.82 | Best Trade (Jul 16) $14.72M | Sharpe Ratio -15.14 |
| Average Loss -$13,068.91 | Worst Trade (Dec 30) -$1.68M | Z-Score -2.14 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1w | Expectancy $65,242.06 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 29,412 | 26,471 | 23,529 | 20,588 | 17,647 | 14,706 | 11,765 | 8,824 | 5,882 | 2,941 |